Evaluation of Cancer Prevalence and Cytotoxic Medication Prescribing in Central Region of Nepal

Authors

  • Gulam Muhammad Khan Department of Pharmaceutical Sciences, School of Health and Allied Sciences, Pokhara University, Nepal
  • Raj Kumar Thapa Department of Pharmaceutical Sciences, School of Health and Allied Sciences, Pokhara University, Nepal
  • Dewashish Singh Adhikari Department of Pharmaceutical Sciences, School of Health and Allied Sciences, Pok-hara University, Nepal
  • Muna Rajbhandari Department of Pharmaceutical Sciences, School of Health and Allied Sciences, Pokhara University, Nepal
  • Pratibha Dwa Department of Pharmaceutical Sciences, School of Health and Allied Sciences, Pokhara University, Nepal
  • Saroj Shrestha Department of Pharmaceutical Sciences, School of Health and Allied Sciences, Pokhara University, Nepal

DOI:

https://doi.org/10.3126/kuset.v9i1.63923

Keywords:

Cancer, Cytotoxic drugs, Nepal

Abstract

In this study, our objective was to evaluate the cancer prevalence and inpatient prescribing pattern of cytotoxic medicines in one of the major tertiary care hospitals for cancer treatment in the central region of Nepal. A retrospective cross-sectional descriptive study was conducted. A modified data collection form was used to collect information on patient demographics and prescribed drugs. Females were found to be more susceptible to cancer than males. 58 different types of cancer were observed, with reproductive, respiratory, and digestive cancers being prevalent. A total of 427 cytotoxic drugs were prescribed. The alkylating agent group of cytotoxics was the most frequently prescribed one (45.67%). The average number of drugs prescribed per prescription, cytotoxic drugs per prescription, antibiotics per prescription, and other drugs per prescription were 10.77, 1.78, 0.37, and 8.99 respectively. The cytotoxic drugs were prescribed by brand names according to hospital policy. The drugs prescribed from the World Health Organization (WHO) model list of essential drugs and the essential drug list of Nepal were 67.40% and 73.72% respectively. The percentage of encounters with antibiotics and injections prescribed were 31.25% and 100% respectively.

Downloads

Download data is not yet available.
Abstract
105
PDF
36

Downloads

Published

2013-07-31

How to Cite

Khan, G. M., Thapa, R. K., Adhikari, D. S., Rajbhandari, M., Dwa, P., & Shrestha, S. (2013). Evaluation of Cancer Prevalence and Cytotoxic Medication Prescribing in Central Region of Nepal. Kathmandu University Journal of Science, Engineering and Technology, 9(1), 189–199. https://doi.org/10.3126/kuset.v9i1.63923

Issue

Vol. 9 No. 1 (2013)

Section

Original Research Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.